Peng, Hongyan
Chen, Feiyan
Zuo, Yunlong
Huang, Bolun
Yang, Yiyu
Dang, Run
Article History
Received: 13 August 2021
Accepted: 14 March 2022
First Online: 22 March 2022
Declarations
:
: This study was approved by the ethics committee of Guangzhou Women and Children’s Medical Center (Approval number: 2016102420). Signed informed consents were obtained from pediatric parents or guardians for high titer NAbs plasma treatment. All methods were performed in accordance with the provisions of the Declaration of Helsinki.
: Not applicable.
: The authors declare that no competing interests exist.